C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/1999
10/19/1999	US5968581 Dipeptide derivatives and sweetening agents
10/19/1999	US5968477 Radiolabeled annexin conjugates with hexose and a chelator
10/14/1999	WO1999051720A2 Methods for production of therapeutic cytokines
10/14/1999	WO1999051624A1 Reagents and methods for inhibiting furin protease activity
10/14/1999	WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999	WO1999044628A8 Conjugates useful in the treatment of prostate cancer
10/14/1999	DE19815812A1 New camptothecin derivatives useful as cytostatic agents for treating cancer
10/14/1999	CA2327814A1 Reagents and methods for inhibiting furin protease activity
10/14/1999	CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999	CA2268586A1 Process for producing n-glycyltyrosine and its crystal structure
10/13/1999	EP0948640A2 Improved substrates for human cytomegalovirus protease
10/13/1999	EP0948539A2 Peptides and compounds that bind to a receptor
10/13/1999	EP0948524A1 Peptides agonists of bradykinine b 2? receptor
10/13/1999	EP0948523A1 Peptidomimetic inhibitors of the human cytomegalovirus protease
10/13/1999	EP0948344A1 Synthetic antibiotics
10/13/1999	EP0948258A1 Brain targeted low molecular weight hydrophobic antioxidant compounds
10/13/1999	CN1231671A Antithrombotic azacycloalkylakanoyl peptides and pseudopeptides
10/13/1999	CN1231659A Stable non-hygroscopic crystalline form of N-[N-N-(4-(piperidin-4-YL) butanoyl)-N-ethylglycyl] compound
10/13/1999	CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease
10/13/1999	CN1045594C Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
10/12/1999	US5965770 Chiral purity; synthetic peptides used as reagents for analytical tests, sweetening agents, synthetic hormones
10/12/1999	US5965701 Kappa receptor opioid peptides
10/12/1999	US5965700 Preparation of active peptides
10/12/1999	US5965695 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
10/12/1999	US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999	US5965601 Novel compounds for inhibiting replication of a retrovirus; treating hiv
10/12/1999	US5965586 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
10/12/1999	US5965585 Suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering a hydroxypyridone compound enzyme inhibitor of protein hydroxylase; antiscarring agents
10/12/1999	US5965539 Peptidomimetics; anti-cancer drugs
10/12/1999	US5965538 Azapeptide derivative
10/12/1999	US5965537 Anticancer agents; water solubility
10/12/1999	US5965532 Low molecular weight, synthetic crosslinking boron compounds as an agonists or antagonists and induce association between naturally occurring receptors, t cell surface receptor
10/12/1999	US5965108 Cyclic peptide-metal complex specifically binds to surface somatostatin receptor-expressing cells; radiology; scintigraphy; antitumor,-carcinogenic and metastatic agents; stability
10/07/1999	WO1999050283A1 High throughput screening assays for modulators of stat4 and stat6 activity
10/07/1999	WO1999049891A1 Compositions and methods for providing a vpr-binding protein to a virion
10/07/1999	WO1999032509A3 Hemiasterlin analogs
10/06/1999	EP0946588A1 Use of dipeptide derivatives
10/06/1999	EP0946526A1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/06/1999	EP0946516A1 New histidine derivatives, preparation process, and their use as free antiradical agents
10/06/1999	EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999	EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999	EP0842190B1 Process for producing dolastatin 15 and intermediates thereof
10/06/1999	EP0832900A4 Peptide and method of obtaining it
10/06/1999	CN1045448C Using seryl histidine, phosphorylated serine, phosphorylated threonine as nucleic chipping agent
10/06/1999	CN1045431C 15-deoxyspergualin analogs, their preparation method, compositions, intermediate and use in preparation of medicine thereof
10/05/1999	US5962722 Used in peptide synthesis
10/05/1999	US5962696 Drying in carbon dioxide; by-product inhibition; simplification
10/05/1999	US5962506 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
10/05/1999	US5962502 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
10/05/1999	US5962487 Picornaviral 3c protease inhibitors
10/05/1999	US5962419 Nervous system disorders; brain disorders
10/05/1999	US5962243 Assaying for presence of farnesyl protein transferase activity in an enzyme composition by determining transfer of moiety to k-rasb protein or k-rasb peptide having farnesyl acceptor
09/1999
09/30/1999	WO1999048913A1 Peptide turn mimetics
09/30/1999	WO1999048911A1 Monobactam enzyme inhibitors
09/30/1999	WO1999048910A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
09/30/1999	WO1999048522A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
09/30/1999	WO1999048513A1 Methods and compositions for peptide synthesis
09/30/1999	WO1999031122A9 Antipicornaviral compounds and methods for their use and preparation
09/30/1999	DE19813137A1 New camptothecin glyco-conjugate compounds
09/30/1999	CA2324566A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
09/30/1999	CA2323063A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
09/29/1999	EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
09/29/1999	EP0944639A1 Synthetic glycoamines, methods for their use that affect cell
09/29/1999	EP0944597A1 Metalloproteinase inhibitors
09/29/1999	EP0944582A1 Ketobenzamides as calpain inhibitors
09/29/1999	CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn.
09/29/1999	CN1230195A Treatment of immune disorders
09/29/1999	CN1230120A Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof
09/29/1999	CN1230110A Cell adhesion inhibitors
09/28/1999	US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections
09/28/1999	US5958885 Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood
09/28/1999	US5958882 Compounds that inhibit T cell proliferation and methods using the same
09/28/1999	US5958496 Low calorie sweetening for food, beverages; taste, stability
09/28/1999	US5958457 Compositions for the delivery of antigens
09/28/1999	US5958424 Recombinant chicken anemia virus particle
09/28/1999	CA2075307C Method for recovery of .alpha.-l-aspartyl-l-phenylalanine methyl ester, l-phenylalanine and l-aspartic acid
09/23/1999	WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses
09/23/1999	WO1999047549A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase)
09/23/1999	WO1999047548A1 Process for the preparation of a tetrapeptide
09/23/1999	WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity
09/23/1999	WO1999047546A1 Hydroxyproline derivatives
09/23/1999	WO1999047545A2 Inhibitors of caspases
09/23/1999	WO1999047154A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999	WO1999038821A3 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
09/23/1999	WO1999032510A9 Kappa receptor opioid peptides
09/23/1999	CA2403836A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999	CA2323808A1 Hydroxyproline derivatives
09/23/1999	CA2323678A1 Process for the preparation of a tetrapeptide
09/23/1999	CA2323439A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999	CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses
09/23/1999	CA2289621A1 Piperazines as inhibitors of fructose-1,6-bisphosphatase (fbpase)
09/22/1999	EP0943623A1 Cyclic hexapeptide antifungal agents
09/22/1999	EP0943621A2 Process for the production of alkoxycarbonylpeptides intermediates in the synthesis of the lisinopril
09/22/1999	EP0943096A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF
09/22/1999	EP0942925A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
09/22/1999	EP0942924A2 METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS
09/22/1999	EP0942923A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
09/22/1999	EP0615522B1 Muramyl compounds for treatment of septic shock
09/22/1999	CN1229414A Multivalent compounds for cross-linking receptors and uses thereof
09/22/1999	CN1229412A Inhibitors of interleukin-1'beta' converting emzyme

1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 307